The Short Answer
BioMarin stock (BMRN) is generally considered halal for Muslim investors, subject to the balance-sheet ratios. BioMarin Pharmaceutical develops and markets therapies for serious and life-threatening rare genetic diseases, including enzyme-replacement therapies, small molecules, and gene therapy. Developing and selling medicines that treat rare diseases is a permissible activity, so the business-activity screen passes.
The verdict depends on the balance sheet: BioMarin has historically used convertible notes and other financing, so confirm the total-debt-to-market-cap ratio against the 33% threshold using the latest filings, and purify the interest income on cash.
Sharia Screening Methodology
Islamic scholars use several criteria to screen stocks:
- Business activity screen: Is the company's primary business halal?
- Debt ratio: Total debt / market cap must be under 33%
- Interest income: Interest income / total revenue must be under 5%
- Haram revenue: Revenue from haram sources must be under 5%
- Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)
What BioMarin Does
BioMarin Pharmaceutical Inc. (headquartered in San Rafael, California) develops and markets therapies for rare genetic diseases:
- Enzyme-replacement therapies: Treatments for rare metabolic disorders.
- Small molecules: Including therapies for skeletal and metabolic conditions.
- Gene therapy: Gene-transfer programs for rare genetic diseases.
Developing and selling medicines that treat rare diseases is a permissible activity, so the business-activity screen passes.
Why It Passes (and What to Check)
1. Permissible Core Business
BioMarin's revenue comes from therapies that treat rare genetic diseases — a clearly permissible activity that benefits human health. There is no haram revenue line.
2. Debt Ratio (Deciding Screen)
BioMarin has historically used convertible notes and other financing, so confirm the total-debt-to-market-cap ratio against the 33% threshold using the latest filings. This is the deciding screen for the verdict.
3. Interest Income (Purify)
BioMarin earns interest income on its cash and investment balances. This should be checked against the 5% threshold and the corresponding portion of returns purified.
Financial Ratios
Based on BioMarin's most recent financial statements:
- Total Debt / Market Cap: Confirm against filings ⚠️ (threshold: under 33%)
- Interest Income: On cash/investments — check and purify ⚠️ (threshold: under 5%)
- Haram Revenue: None ✅ (threshold: under 5%)
- Receivables Ratio: Confirm against filings ⚠️ (threshold: 49–70%, varies by board)
Assuming the ratios hold, BMRN screens as halal — clinical, regulatory, and pricing risk make the business volatile, so re-screen periodically.
What About Purification?
Purify the portion of returns attributable to interest income earned on BioMarin's cash and investment balances — donating that share of gains to charity.
Verdict from Major Screening Agencies
BioMarin stock is generally screened as halal by:
- Zoya App — Compliant subject to ratios ✅
- MSCI Islamic criteria — Compliant subject to debt ratio ✅
- Most major Sharia advisory boards — Halal with routine purification ✅
Bottom Line
BioMarin (BMRN) is generally halal for Muslim investors, subject to the balance-sheet ratios. The rare-disease medicine business is clearly permissible. Confirm the debt and receivables ratios against the latest filings — the convertible-note financing makes the debt screen the deciding one — purify the interest income, and re-screen periodically.
Want to check if another stock is halal? Use our free screener.
Open Halal Checker →